{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:05:06Z","timestamp":1790766306777,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antiretroviral therapy for pregnant women infected with HIV has evolved significantly over time, from single dosage antiretroviral and zidovudine alone to lifelong combination of antiretroviral therapy, but the effect of the intervention on population-level child HIV infection has not been well studied in sub-Saharan Africa. Therefore, this study aimed to establish the trend and effect of ART coverage during pregnancy on mother-to-child HIV transmission in sub-Saharan Africa from 2010 to 2019.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Country-level longitudinal ecological study design was used. Forty-one sub-Saharan Africa countries were included using publicly available data from the United Nations Programme on HIV\/AIDS, World Health Organization, and World Bank. We created a panel dataset of 410 observations for this study from the years 2010\u20132019. Linear fixed effects dummy variable regression models were conducted to measure the effect of ART coverage during pregnancy on MTCT rate. Regression coefficients with their 95% confidence intervals (CIs) were estimated for each variable from the fixed effects model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>ART coverage during pregnancy increased from 32.98 to 69.46% between 2010 and 2019. Over the same period, the rate of HIV transmission from mother to child reduced from 27.18 to 16.90% in sub-Saharan Africa. A subgroup analysis found that in southern Africa and upper-middle-income groups, higher ART coverage, and lower MTCT rates were recorded. The fixed-effects model result showed that ART coverage during pregnancy (<jats:italic>\u03b2<\/jats:italic>\u2009=\u2009\u2212\u00a00.18, 95% CI \u2212\u00a00.19\u2013\u2212\u00a00.16) (p\u2009&lt;\u20090.001) and log-transformed HIV incidence-to-prevalence ratio (<jats:italic>\u03b2<\/jats:italic>\u2009=\u20095.41, 95% CI 2.18\u20138.65) (p\u2009&lt;\u20090.001) were significantly associated with mother-to-child HIV transmission rate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ART coverage for HIV positive pregnant women and HIV incidence-to-prevalence ratio were significantly associated with MTCT rate in sub-Saharan Africa. Based on these findings we suggest countries scale up ART coverage by implementing varieties of proven strategies and control the HIV epidemic to achieve the global target of eliminating MTCT of HIV in the region.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07119-6","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T10:03:44Z","timestamp":1644314624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Trends and effects of antiretroviral therapy coverage during pregnancy on mother-to-child transmission of HIV in Sub-Saharan Africa. Evidence from panel data analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Feleke Hailemichael","family":"Astawesegn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Stulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"7119_CR1","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection Geneva, Switzerland WHO; 2016. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/208825\/9789241549684_eng.pdf?sequence=1. Accessed 20 Dec 2020."},{"issue":"4","key":"7119_CR2","doi-asserted-by":"publisher","first-page":"e35268","DOI":"10.1371\/journal.pone.0035268","volume":"7","author":"L Tudor Car","year":"2012","unstructured":"Tudor Car L, Van Velthoven MH, Brusamento S, Elmoniry H, Car J, Majeed A, et al. Integrating prevention of mother-to-child HIV transmission programs to improve uptake: a systematic review. PLoS ONE. 2012;7(4):e35268.","journal-title":"PLoS ONE"},{"key":"7119_CR3","unstructured":"World Health Organization . PMTCT strategic vision 2010\u20132015 Geneva: WHO; 2010. https:\/\/www.who.int\/hiv\/pub\/mtct\/strategic_vision.pdf?ua=1. Accessed 20 Jan 2020."},{"key":"7119_CR4","unstructured":"United Nations Joint Program on HIV\/AIDS. Ending AIDS: progress towards the 90\u201390\u201390 targets Geneva: UNAIDS; https:\/\/reliefweb.int\/report\/world\/ending-aids-progress-towards-90-90-90-targets. Accessed 20 Jan 2020."},{"key":"7119_CR5","unstructured":"World Health Organization. Global guidance on criteria and processes for validation: Elimination of mother-to-child transmission of HIV and Syphilis, Second edition Geneva, Switzerland WHO; 2017 https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259517\/9789241513272-eng.pdf?sequence=1. Accessed 2 Jan 2021."},{"key":"7119_CR6","unstructured":"The United Nations Programme. On the fast-track to an AIDS-free generation. The incredible journey of the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive 2016 [Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/GlobalPlan2016_en.pdf. Accessed 26 May 2021."},{"key":"7119_CR7","unstructured":"World Health Organization. Antiretroviral drugs for treating pregnant women and preventing hiv infection in infants Recommendations for a public health approach 2010 version Geneva, Switzerland: WHO; 2010. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/75236\/9789241599818_eng.pdf?sequence=1. Accessed 23 Feb 2021."},{"key":"7119_CR8","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection Recommendations for a public health approach - Second edition Geneva, Switzerland WHO; 2016 [Available from: https:\/\/www.who.int\/hiv\/pub\/arv\/arv-2016\/en\/. Accessed 21 Jan 2021."},{"key":"7119_CR9","unstructured":"United Nations Joint Program on HIV\/AIDS. UNAIDS 90\u201390\u201390 An ambitious treatment target to help end the AIDS epidemic Geneva: UNAIDS; 2014. https:\/\/pancap.org\/pc\/pcc\/media\/pancap_document\/90-90-90_Targets.pdf. Accessed 27 Jan 2020."},{"key":"7119_CR10","unstructured":"Joint United Nations Programme on HIV\/AIDS. Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive UNAIDS 2011. http:\/\/files.unaids.org\/en\/media\/unaids\/contentassets\/documents\/unaidspublication\/2011\/20110609_JC2137_Global-Plan-Elimination-HIV-Children_en.pdf. Accessed 21 Jan 2021."},{"key":"7119_CR11","unstructured":"Joint United Nations Programme on HIV\/AIDS. Together we will end AIDS. 2012. https:\/\/files.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2012\/JC2296_UNAIDS_TogetherReport_2012_en.pdf Accessed 13 Feb 2021."},{"key":"7119_CR12","unstructured":"World Health Organization. HIV\/AIDS key factos 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids. Accessed 29 Dec 2020."},{"key":"7119_CR13","unstructured":"Global Statistics. The Global HIV\/AIDS Epidemic 2020. https:\/\/www.hiv.gov\/hiv-basics\/overview\/data-and-trends\/global-statistics. Accessed 29 Dec 2020."},{"key":"7119_CR14","unstructured":"Joint United Nations Programme on HIV\/AIDS . UNAIDS FACT SHEET \u2013 GLOBAL HIV STATISTICS WORLD AIDS DAY 2019 Geneva: UNAIDS; 2019. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf. Accessed 20 Apr 2020."},{"key":"7119_CR15","unstructured":"Joint United Nations Programme on HIV\/AIDS. UNAIDS calls for greater urgency as global gains slow and countries show mixed results towards 2020 HIV targets 2019. https:\/\/www.unaids.org\/sites\/default\/files\/20190716_PR_UNAIDS_Global_Report_en.pdf. Accessed 20 Apr 2020."},{"key":"7119_CR16","unstructured":"Joint United Nations Programme on HIV\/AIDS. Prevention gap report 2016. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2016-prevention-gap-report_en.pdf. Accessed 21 Mar 2021."},{"key":"7119_CR17","unstructured":"The United Nations Children\u2019s Fund.. Children, HIV and AIDS Regional snapshot: Sub-Saharan Africa: UNICEF; 2019. https:\/\/www.childrenandaids.org\/sites\/default\/files\/2020-08\/SSA%20Regional%20snapshot-%20v5-%206%20Nov%20%281%29.pdf. Accessed 19 Sep 2020."},{"key":"7119_CR18","unstructured":"World Health Organization. Global health sector response to HIV, 2000\u20132015 focus on innovations in Africa , progress report. Geneva Switzerland WHO; 2015. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/198065\/9789241509824_eng.pdf?sequence=1. Accessed 16 Apr 2021."},{"key":"7119_CR19","unstructured":"Joint United Nations Programme on HIV\/AIDS: UNAIDS and PEPFAR announce dramatic reductions in new HIV infections among children in the 21 countries most affected by HIV in Africa 2016. https:\/\/www.unaids.org\/sites\/default\/files\/20160608_PR_GlobalPlan_en.pdf. Accessed 21 Jan 2021."},{"key":"7119_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12916-015-0342-3","volume":"13","author":"V Tangcharoensathien","year":"2015","unstructured":"Tangcharoensathien V, Mills A, Palu T. Accelerating health equity: the key role of universal health coverage in the Sustainable Development Goals. BMC Med. 2015;13:101.","journal-title":"BMC Med"},{"issue":"5","key":"7119_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pbj.2017.08.001","volume":"2","author":"M Raviglione","year":"2017","unstructured":"Raviglione M, Maher D. Ending infectious diseases in the era of the Sustainable Development Goals. Porto Biomed J. 2017;2(5):140\u20132.","journal-title":"Porto Biomed J"},{"key":"7119_CR22","unstructured":"UNICEF, UNAIDS, WHO . Key considerations for programming and prioritization. going the \u2018LAST MILE\u2019 to EMTCT:: A road map for ending the HIV epidemic in children 2020. http:\/\/www.childrenandaids.org\/sites\/default\/files\/2020-02\/Last-Mile-To-EMTCT_WhitePaper_UNICEF2020.pdf. Accessed 2 Jan 2021."},{"issue":"10144","key":"7119_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0140-6736(18)31070-5","volume":"392","author":"L-G Bekker","year":"2018","unstructured":"Bekker L-G, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, et al. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet. 2018;392(10144):312\u201358.","journal-title":"Lancet"},{"key":"7119_CR24","unstructured":"Gray G. HIV, AIDS and 90\u201390\u201390: what is it and why does it matter? South Africa: the Conversation; 2016 [cited 2020 January 27]. https:\/\/theconversation.com\/hiv-aids-and-90-90-90-what-is-it-and-why-does-it-matter-62136. Accessed 27 Jan 2020."},{"issue":"2","key":"7119_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S2055-6640(20)30058-3","volume":"5","author":"J Kempton","year":"2019","unstructured":"Kempton J, Hill A, Levi JA, Heath K, Pozniak A. Most new HIV infections, vertical transmissions and AIDS-related deaths occur in lower-prevalence countries. J Virus Erad. 2019;5(2):92\u2013101.","journal-title":"J Virus Erad"},{"key":"7119_CR26","unstructured":"The United Nations Children's Fund. Children, HIV and AIDS Regional snapshot: Sub-Saharan Africa: UNICEF 2019. https:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/Children%2C%20HIV%20and%20AIDS%20Regional%20snapshot%20-%20Sub-Saharan%20Africa%20%28December%202019%29.pdf. Accessed 20 Jan 2021."},{"key":"7119_CR27","unstructured":"Joint United Nations Programme on HIV\/AIDS. Seizing the moment: Tackling entrenched inequalities to end epidemics: UNAIDS; 2020 .https:\/\/www.thejakartapost.com\/academia\/2020\/07\/08\/seizing-the-moment-tackling-entrenched-inequalities-to-end-epidemics.html. Accessed 23 Feb 2021."},{"key":"7119_CR28","unstructured":"World Health Organization. End HIV\/AIDS by 2030 HIV\/AIDS: framework for action in the who African region, 2016\u20132020. Geneva: WHO; 2017. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259638\/EndAIDS-eng.pdf?sequence=1. Accessed 23 Feb 2021."},{"key":"7119_CR29","unstructured":"UNICEF Data: Monitoring the situation of children and women. Elimination of mother-to-child transmission 2020. Available from: https:\/\/data.unicef.org\/topic\/hivaids\/emtct\/. Accessed 16 Apr 2021."},{"key":"7119_CR30","unstructured":"United Nations Joint Program on HIV\/AIDS. AIDSinfo. http:\/\/aidsinfo.unaids.org\/. Accessed 16 Apr 2021."},{"key":"7119_CR31","unstructured":"MEASURING THE IMPACT OF NATIONAL PMTCT PROGRAMMES Towards the Elimination of New HIV Infections Among Children by 2015 and Keeping Their Mothers Alive 2012. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/75478\/9789241504362_eng.pdf;jsessionid=413FE57C3880B40DD62C2A4FF382731F?sequence=1. Accessed 20 Mar 2021."},{"key":"7119_CR32","unstructured":"Joint United Nations Programme on HIV\/AIDS. The sustainable development goals and the HIV response. Stories of putting people at the centre. Joint United Nations Programme on HIV\/AIDS, Geneva. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/SDGsandHIV_en.pdf. Accessed Apr 2020."},{"key":"7119_CR33","unstructured":"World Health Organization, The Global Health Observatory. Explore a world of health data. https:\/\/www.who.int\/data\/gho\/data\/indicators. Accessed 2 Feb 2021."},{"key":"7119_CR34","unstructured":"The world bank. working for a world free of poverty. 2020. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups. Accessed 2 Feb 2021."},{"key":"7119_CR35","unstructured":"World Health Organization. Consolidated HIV strategic information guidelines. Driving impact through programme monitoring and management 2020. https:\/\/www.who.int\/publications\/i\/item\/consolidated-hiv-strategic-information-guidelines. Accessed 10 Dec 2020."},{"key":"7119_CR36","unstructured":"United Nations Joint Program on HIV\/AIDS. Core Indicators for National AIDS Programmes. Guidance and Specifications for Additional Recommended Indicators 2007. https:\/\/data.unaids.org\/pub\/basedocument\/2009\/20090305_additionalrecommendedindicators_finalprintversio_en.pdf. Accessed 10 Dec 2020."},{"issue":"927","key":"7119_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/pmj.79.927.36","volume":"79","author":"HK Thaker","year":"2003","unstructured":"Thaker HK, Snow MH. HIV viral suppression in the era of antiretroviral therapy. Postgrad Med J. 2003;79(927):36\u201342.","journal-title":"Postgrad Med J"},{"issue":"6","key":"7119_CR38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493\u2013505.","journal-title":"N Engl J Med"},{"issue":"4 Suppl 3","key":"7119_CR39","doi-asserted-by":"publisher","first-page":"19612","DOI":"10.7448\/IAS.17.4.19612","volume":"17","author":"A Reepalu","year":"2014","unstructured":"Reepalu A, Balcha TT, Skogmar S, Jemal ZH, Sturegard E, Medstrand P, et al. High rates of viral suppression in a cohort of HIV-positive adults receiving ART in Ethiopian health centers irrespective of concomitant tuberculosis. J Int Aids Soc. 2014;17(4 Suppl 3):19612.","journal-title":"J Int Aids Soc"},{"issue":"6","key":"7119_CR40","doi-asserted-by":"publisher","first-page":"e11068","DOI":"10.1371\/journal.pone.0011068","volume":"5","author":"M Das","year":"2010","unstructured":"Das M, Chu PL, Santos G-M, Scheer S, Vittinghoff E, McFarland W, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE. 2010;5(6):e11068.","journal-title":"PLoS ONE"},{"key":"7119_CR41","unstructured":"United Nations Programme on HIV\/AIDS. UNAIDS DATA 2020, ADVANCING TOWARDS THE THREE ZEROS 2020. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2020_aids-data-book_en.pdf. Accessed 16 Apr 2021."},{"key":"7119_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c6269","author":"JSA Stringer","year":"2010","unstructured":"Stringer JSA, Guffey MB. Transmission of HIV to infants whose mothers seroconvert postnatally. Brit Med J. 2010. https:\/\/doi.org\/10.1136\/bmj.c6269.","journal-title":"Brit Med J."},{"key":"7119_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125525","author":"TH Dinh","year":"2015","unstructured":"Dinh TH, Delaney KP, Goga A, Jackson D, Lombard C, Woldesenbet S, et al. Impact of maternal hiv seroconversion during pregnancy on early mother to child transmission of HIV (MTCT) measured at 4\u20138 weeks postpartum in South Africa 2011\u20132012: a national population-based evaluation. PLoS ONE. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0125525.","journal-title":"PLoS ONE"},{"issue":"11","key":"7119_CR44","doi-asserted-by":"publisher","first-page":"e0165627","DOI":"10.1371\/journal.pone.0165627","volume":"11","author":"GA Tessema","year":"2016","unstructured":"Tessema GA, Streak Gomersall J, Mahmood MA, Laurence CO. Factors determining quality of care in family planning services in africa: a systematic review of mixed evidence. PLoS ONE. 2016;11(11):e0165627.","journal-title":"PLoS ONE"},{"issue":"2","key":"7119_CR45","first-page":"268","volume":"147","author":"HK van Dijk","year":"1999","unstructured":"van Dijk HK. Topics in advanced econometrics, estimation, testing and specification of cross-section and time-series models. Economist. 1999;147(2):268\u20139.","journal-title":"Economist"},{"issue":"2","key":"7119_CR46","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/ajps.12417","volume":"63","author":"ISK Kosuke Imai","year":"2019","unstructured":"Kosuke Imai ISK. When should we use unit fixed effects regression models for causal inference with longitudinal data? Am J Poli Sci. 2019;63(2):467\u201390.","journal-title":"Am J Poli Sci"},{"issue":"1","key":"7119_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/ije\/dyt221","volume":"43","author":"FI Gunasekara","year":"2014","unstructured":"Gunasekara FI, Richardson K, Carter K, Blakely T. Fixed effects analysis of repeated measures data. Int J Epidemiol. 2014;43(1):264\u20139.","journal-title":"Int J Epidemiol"},{"issue":"12","key":"7119_CR48","doi-asserted-by":"publisher","first-page":"e688","DOI":"10.1016\/S2352-3018(18)30316-3","volume":"5","author":"BA Tippett Barr","year":"2018","unstructured":"Tippett Barr BA, van Lettow M, van Oosterhout JJ, Landes M, Shiraishi RW, Amene E, et al. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis. Lancet HIV. 2018;5(12):e688\u201395.","journal-title":"Lancet HIV"},{"issue":"12","key":"7119_CR49","doi-asserted-by":"publisher","first-page":"827","DOI":"10.7196\/SAMJ.4045","volume":"100","author":"FC Fitzgerald","year":"2010","unstructured":"Fitzgerald FC, Bekker L-G, Kaplan R, Myer L, Lawn SD, Wood R. Mother-to-child transmission of HIV in a community-based antiretroviral clinic in South Africa. S Afr Med J. 2010;100(12):827\u201331.","journal-title":"S Afr Med J"},{"key":"7119_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s41256-019-0121-3","volume":"4","author":"BA Larson","year":"2019","unstructured":"Larson BA, Halim N, Tsikhutsu I, Bii M, Coakley P, Rockers PC. A tool for estimating antiretroviral medication coverage for HIV-infected women during pregnancy (PMTCT-ACT). Glob Health Res Policy. 2019;4:29.","journal-title":"Glob Health Res Policy"},{"issue":"1","key":"7119_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/QAI.0b013e3181cf9979","volume":"54","author":"RM Hoffman","year":"2010","unstructured":"Hoffman RM, Black V, Technau K, van der Merwe KJ, Currier J, Coovadia A, et al. Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2010;54(1):35\u201341.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"7119_CR52","doi-asserted-by":"publisher","first-page":"020405","DOI":"10.7189\/jogh.06.020405","volume":"6","author":"AE Goga","year":"2016","unstructured":"Goga AE, Dinh T-H, Jackson DJ, Lombard CJ, Puren A, Sherman G, et al. Population-level effectiveness of PMTCT Option A on early mother-to-child (MTCT) transmission of HIV in South Africa: implications for eliminating MTCT. J Glob Health. 2016;6(2):020405.","journal-title":"J Glob Health"},{"issue":"2","key":"7119_CR53","doi-asserted-by":"publisher","first-page":"e0212587","DOI":"10.1371\/journal.pone.0212587","volume":"14","author":"KM Zacharius","year":"2019","unstructured":"Zacharius KM, Basinda N, Marwa K, Mtui EH, Kalolo A, Kapesa A. Low adherence to Option B+ antiretroviral therapy among pregnant women and lactating mothers in eastern Tanzania. PLoS ONE. 2019;14(2):e0212587.","journal-title":"PLoS ONE"},{"issue":"9","key":"7119_CR54","doi-asserted-by":"publisher","first-page":"e106325","DOI":"10.1371\/journal.pone.0106325","volume":"9","author":"A Gourlay","year":"2014","unstructured":"Gourlay A, Wringe A, Birdthistle I, Mshana G, Michael D, Urassa M. \u201cIt is like that, we didn\u2019t understand each other\u201d: exploring the influence of patient-provider interactions on prevention of mother-to-child transmission of HIV service use in rural Tanzania. PLoS ONE. 2014;9(9):e106325.","journal-title":"PLoS ONE"},{"issue":"67 Suppl 2","key":"7119_CR55","first-page":"S108","volume":"2014","author":"N Rollins","year":"1999","unstructured":"Rollins N, Chanza H, Chimbwandira F, Eliya M, Nyasulu I, Thom E, et al. Prioritizing the PMTCT implementation research agenda in 3 African countries: INtegrating and Scaling up PMTCT through Implementation REsearch (INSPIRE). J Acquir Immune Defic Syndr. 1999;2014(67 Suppl 2):S108\u201313.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"7119_CR56","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1186\/s12889-018-5651-y","volume":"18","author":"O Omonaiye","year":"2018","unstructured":"Omonaiye O, Kusljic S, Nicholson P, Manias E. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review. BMC Public Health. 2018;18(1):805.","journal-title":"BMC Public Health"},{"issue":"1","key":"7119_CR57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/QAD.0000000000002027","volume":"33","author":"EJ Abrams","year":"2019","unstructured":"Abrams EJ, Langwenya N, Gachuhi A, Zerbe A, Nuwagaba-Biribonwoha H, Mthethwa-Hleta S, et al. Impact of universal antiretroviral therapy for pregnant and postpartum women on antiretroviral therapy uptake and retention. AIDS. 2019;33(1):45\u201354.","journal-title":"AIDS"},{"issue":"1","key":"7119_CR58","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12884-017-1276-x","volume":"17","author":"E Buregyeya","year":"2017","unstructured":"Buregyeya E, Naigino R, Mukose A, Makumbi F, Esiru G, Arinaitwe J, et al. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study. BMC Pregnancy Childbirth. 2017;17(1):94.","journal-title":"BMC Pregnancy Childbirth"},{"key":"7119_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008440","author":"AS Sturt","year":"2010","unstructured":"Sturt AS, Dokubo EK, Sint TT. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev. 2010. https:\/\/doi.org\/10.1002\/14651858.CD008440.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"7119_CR60","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/QAI.0000000000001616","volume":"77","author":"BA Knettel","year":"2018","unstructured":"Knettel BA, Cichowitz C, Ngocho JS, Knippler ET, Chumba LN, Mmbaga BT, et al. Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa. J Acquir Immune Defic Syndr. 2018;77(5):427\u201338.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"7119_CR61","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/heapol\/czw025","volume":"31","author":"J Karnon","year":"2016","unstructured":"Karnon J, Orji N. Option B+ for the prevention of mother-to-child transmission of HIV infection in developing countries: a review of published cost-effectiveness analyses. Health Policy Plan. 2016;31(8):1133\u201341.","journal-title":"Health Policy Plan"},{"issue":"2","key":"7119_CR62","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/QAI.0b013e3181fdbf20","volume":"56","author":"PM Barker","year":"2011","unstructured":"Barker PM, Mphatswe W, Rollins N. Antiretroviral drugs in the cupboard are not enough: the impact of health systems\u2019 performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2011;56(2):e45\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"7119_CR63","doi-asserted-by":"publisher","first-page":"e1001424","DOI":"10.1371\/journal.pmed.1001424","volume":"10","author":"JSA Stringer","year":"2013","unstructured":"Stringer JSA, Stinson K, Tih PM, Giganti MJ, Ekouevi DK, Creek TL, et al. Measuring coverage in MNCH: population HIV-free survival among children under two years of age in four African countries. Plos Med. 2013;10(5):e1001424.","journal-title":"Plos Med"},{"key":"7119_CR64","doi-asserted-by":"publisher","first-page":"26308","DOI":"10.3402\/gha.v8.26308","volume":"8","author":"EC Larsson","year":"2015","unstructured":"Larsson EC, Ekstrom AM, Pariyo G, Tomson G, Sarowar M, Baluka R, et al. Prevention of mother-to-child transmission of HIV in rural Uganda: modelling effectiveness and impact of scaling-up PMTCT services. Glob Health Action. 2015;8:26308.","journal-title":"Glob Health Action"},{"issue":"9","key":"7119_CR65","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/infdis\/jir017","volume":"203","author":"D Moodley","year":"2011","unstructured":"Moodley D, Esterhuizen T, Reddy L, Moodley P, Singh B, Ngaleka L, et al. Incident HIV infection in pregnant and lactating women and its effect on mother-to-child transmission in South Africa. J Infect Dis. 2011;203(9):1231\u20134.","journal-title":"J Infect Dis"},{"issue":"4","key":"7119_CR66","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/S2352-3018(16)00019-9","volume":"3","author":"SS Solomon","year":"2016","unstructured":"Solomon SS, Mehta SH, McFall AM, Srikrishnan AK, Saravanan S, Laeyendecker O, et al. Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study. Lancet HIV. 2016;3(4):e183\u201390.","journal-title":"Lancet HIV"},{"issue":"8","key":"7119_CR67","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1097\/QAD.0000000000002224","volume":"33","author":"SM le Roux","year":"2019","unstructured":"le Roux SM, Abrams EJ, Nguyen KK, Myer L. HIV incidence during breastfeeding and mother-tochild transmission in Cape Town South Africa. AIDS. 2019;33(8):1399\u2013401.","journal-title":"AIDS"},{"key":"7119_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039109","author":"MA Keating","year":"2012","unstructured":"Keating MA, Hamela G, Miller WC, Moses A, Hoffman IF, Hosseinipour MC. High HIV Incidence and sexual behavior change among pregnant women in Lilongwe, Malawi: implications for the risk of HIV acquisition. PLoS ONE. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0039109.","journal-title":"PLoS ONE"},{"issue":"9492","key":"7119_CR69","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(05)67481-8","volume":"366","author":"RH Gray","year":"2005","unstructured":"Gray RH, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet. 2005;366(9492):1182\u20138.","journal-title":"Lancet"},{"issue":"10","key":"7119_CR70","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1097\/QAD.0b013e32832a5934","volume":"23","author":"D Moodley","year":"2009","unstructured":"Moodley D, Esterhuizen TM, Pather T, Chetty V, Ngaleka L. High HIV incidence during pregnancy: compelling reason for repeat HIV testing. AIDS (London, England). 2009;23(10):1255\u20139.","journal-title":"AIDS (London, England)"},{"issue":"2","key":"7119_CR71","doi-asserted-by":"publisher","first-page":"e1001608","DOI":"10.1371\/journal.pmed.1001608","volume":"11","author":"AL Drake","year":"2014","unstructured":"Drake AL, Wagner A, Richardson B, John-Stewart G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. Plos Med. 2014;11(2):e1001608.","journal-title":"Plos Med"},{"issue":"4","key":"7119_CR72","first-page":"417","volume":"59","author":"LF Johnson","year":"2012","unstructured":"Johnson LF, Stinson K, Newell M-L, Bland RM, Moultrie H, Davies M-A, et al. The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. JAIDS. 2012;59(4):417\u201325.","journal-title":"JAIDS"},{"issue":"Suppl 1","key":"7119_CR73","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/QAD.0000000000001306","volume":"31","author":"M Mahy","year":"2017","unstructured":"Mahy M, Penazzato M, Ciaranello A, Mofenson L, Yianoutsos CT, Davies MA, et al. Improving estimates of children living with HIV from the Spectrum AIDS Impact Model. AIDS. 2017;31(Suppl 1):S13\u201322.","journal-title":"AIDS"},{"issue":"Suppl 2","key":"7119_CR74","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1097\/QAI.0000000000001357","volume":"75","author":"S Phiri","year":"2017","unstructured":"Phiri S, Tweya H, van Lettow M, Rosenberg NE, Trapence C, Kapito-Tembo A, et al. Impact of facility- and community-based peer support models on maternal uptake and retention in Malawi\u2019s Option B+ HIV prevention of mother-to-child transmission program: a 3-arm cluster randomized controlled trial (PURE Malawi). J Acquir Immune Defic Syndr. 2017;75(Suppl 2):S140\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"7119_CR75","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1016\/S2352-3018(16)00018-7","volume":"3","author":"MH Aliyu","year":"2016","unstructured":"Aliyu MH, Blevins M, Audet CM, Kalish M, Gebi UI, Onwujekwe O, et al. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial. Lancet HIV. 2016;3(5):e202\u201311.","journal-title":"Lancet HIV"},{"issue":"2","key":"7119_CR76","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/S2352-3018(15)00247-7","volume":"3","author":"M Yotebieng","year":"2016","unstructured":"Yotebieng M, Thirumurthy H, Moracco KE, Kawende B, Chalachala JL, Wenzi LK, et al. Conditional cash transfers and uptake of and retention in prevention of mother-to-child HIV transmission care: a randomised controlled trial. Lancet HIV. 2016;3(2):e85-93.","journal-title":"Lancet HIV"},{"key":"7119_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002547","author":"L Myer","year":"2018","unstructured":"Myer L, Phillips TK, Zerbe A, Brittain K, Lesosky M, Hsiao NY, et al. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: a randomised controlled trial. Plos Med. 2018. https:\/\/doi.org\/10.1371\/journal.pmed.1002547.","journal-title":"Plos Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07119-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07119-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07119-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T10:05:21Z","timestamp":1644314721000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07119-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7119"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07119-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"8 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Given the study design and the use of publicly available data, no ethical approval was considered.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests which may have inappropriately influenced them in writing this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}